People
Luke Bosso focuses on litigating scientific defenses in mass tort litigation. He routinely works with preeminent experts from the world’s leading scientific institutions to analyze issues surrounding exposure, risk, and medical causation. Luke has experience taking expert depositions and has successfully argued to exclude experts in high-stakes litigation. Luke also served as a core member of the science team that successfully excluded Plaintiffs’ general causation experts in a major multi-district litigation and resulted in summary judgment for tens of thousands of claims. Prior to law school, Luke earned a Master of Science degree in Pharmacy, concentrating in Pharmaceutical Outcomes and Policy, which he leverages to distill complex technical issues for judges and juries.
Luke is a member of King & Spalding's LGBTQ+ affinity group and contributes to the firm’s diversity initiatives. Prior to joining the firm, Luke earned his law degree from Georgetown University Law Center. While attending law school, Luke served as the Georgetown Editor-in-Chief of the Food and Drug Law Journal. He also practiced as a student attorney at Georgetown’s medical-legal partnership clinic and taught Street Law in D.C. Public Schools.
J.D., Georgetown University Law Center
M.S., University of Florida
B.A., University of Florida, summa cum laude, Phi Beta Kappa
District of Columbia
Georgia
May 23, 2024
King & Spalding Secures Victory for Boehringer Ingelheim in First Zantac-Related Trial
May 19, 2023
FDA Releases Guidance on Testing High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol
March 30, 2023
Product Testing, Questionable Science, and the Smallest, Big Developments in Consumer Product Litigation
December 20, 2022
Chemical Currents – December 20, 2022
May 23, 2024
King & Spalding Secures Victory for Boehringer Ingelheim in First Zantac-Related Trial
May 19, 2023
FDA Releases Guidance on Testing High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol
March 30, 2023
Product Testing, Questionable Science, and the Smallest, Big Developments in Consumer Product Litigation
December 20, 2022
Chemical Currents – December 20, 2022
May 23, 2024
King & Spalding Secures Victory for Boehringer Ingelheim in First Zantac-Related Trial
J.D., Georgetown University Law Center
M.S., University of Florida
B.A., University of Florida, summa cum laude, Phi Beta Kappa
District of Columbia
Georgia